|
|
| A Full-Service Solution Partner Disrupting the Outsourcing Paradigm | inSeption Group offers a full-service solution designed to disrupt the current outsourcing paradigm, resurrecting a common-sense approach to rebuild business trust and confidence in a client’s selected vendor. Primarily focused on oncology, hematology, neurodegenerative disorders, and rare/orphan disease indications, with a specialization in cell and gene therapy, inSeption has been a solution for its’ clients who have experienced the progressive degradation of today’s outsourcing options. Contact them. |
|
|
|
|
By Liz Oestreich, Kalah Auchincloss, and Erin Hartmann, Eliquent Life Sciences | Of the 190 warning letters that the FDA issued to drug and biopharma manufacturers in fiscal year 2024, this article provides a deep dive on trends pertinent to the 111 inspection-based letters. You may be surprised at some of them. | |
|
|
|
| Optimizing Cell Therapy Supply Chains For Success | e-book | Catalent | When it comes to transporting highly sensitive and valuable materials, such as cell therapies, learn how teams can ensure that unique storage and distribution requirements are met. |
|
|
| Outlook 2025: Key Trends & Insights | Article | Citeline | Dive into the key trends and challenges shaping the year ahead, from geopolitical uncertainties to cutting-edge innovation in AI, oncology, and weight-loss therapies. |
|
|
| Quality Assured: Bringing Life-Changing Therapies To Patients | Article | By Rob Frater and Arthur Stevenson, PCI Pharma Services | Biopharmaceutical drug development remains a key trend, demanding specific expertise and capabilities when it comes to quality assurance. Explore four trends that matter in biologics for clinical trial supply. |
|
|
| Remote Patient Monitoring Using Mobile Health Technology | White Paper | By Dominique G. Stuijt, Eva EM van Doeveren, Milan Kos, et al., CHDR | This study investigates the attitudes of cancer patients towards the adoption of mHealth technologies, including applications and wearable devices, for monitoring purposes during or after their treatment. |
|
|
|
|
.png){kind=logo}
